Getting patients to adhere to long-term therapy for asthma and chronic obstructive pulmonary disease remains a difficult issue to tackle. Conor Mulcahy, Senior Director, Strategic Projects at Nypro, discusses a smart inhaler which could help solve this problem. A trial device called Ruby was created – fully functional but without any drug – to replicate how a smart inhaler is expected to work and to test how best to produce such a device. Smart drug delivery systems hold the promise of personalized medicine as they take advantage of the medical “Internet of Things” to drive significant improvements in medication adherence, patient care and, ultimately, health outcomes. When it comes to chronic disease management, connected drug delivery is the key to modifying behaviors and reducing unnecessary healthcare costs.
For complete article: Read More